Does Dr. WESLEY BOYD have financial conflicts of interest?

Dr. WESLEY BOYD (PA) has received a total of $7,443 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $7,443 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. WESLEY BOYD?

According to CMS Open Payments data, Dr. WESLEY BOYD received funding from ABBVIE ($2,729), SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($920), and TAKEDA PHARMACEUTICALS U.S.A ($421).

Does Dr. WESLEY BOYD receive research grants or speaking fees?

Dr. WESLEY BOYD has received $7,443 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. WESLEY BOYD

PAReal-Time Hydrated

Specialty: Physician Assistant

Practice Location: SOUTHAVEN, MS 38671

NPI Number: 1386097921

LIFETIME INDUSTRY VALUE

$7,443

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BOYD is a verified Physician Assistant practitioner based in SOUTHAVEN, MS.

Between 2021 and 2025, Dr. BOYD had an overall industry promotional and research financial footprint of $7,443 as recorded in the federal CMS Open Payments database.

$7,443 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BOYD's primary funding source is ABBVIE, which accounts for $2,729 (representing 36.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$2,729

36.7%

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 2

$920

12.4%

TAKEDA PHARMACEUTICALS U.S.A

Rank 3

$421

5.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.